Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-19-006578
Filing Date
2019-04-17
Accepted
2019-04-17 16:16:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b50319_actiniumpharma.htm 424B5 857019
2 GRAPHIC actinium_logo.jpg GRAPHIC 138097
3 GRAPHIC actinium_logo1.jpg GRAPHIC 117055
  Complete submission text file 0001213900-19-006578.txt   1208606
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216748 | Film No.: 19753215
SIC: 2834 Pharmaceutical Preparations